An analysis of data from the TREAT Registry found that babies born to women who continued to treat their Crohn’s disease with infliximab during pregnancy had outcomes similar to those who did not take the drug. “The majority of both maternal pregnancies and partner outcomes resulted in live births of healthy infants across exposure groups”
Research published in the journal Alimentary Pharmacology & Therapeutics found ulcerative colitis patients with higher BMIs had a greater likelihood of biologic treatment failure. Increases in BMI also were associated with a higher risk of surgery or hospitalization. The reasons might be related to endogenous steroid production, misuse of medical steroids, or underdosing of conventional
